ID   CHA59
AC   CVCL_GZ61
SY   CHA-59
DR   GEO; GSM1676352
DR   GEO; GSM1701682
DR   NCI-DTP; CHA-59
DR   Wikidata; Q54811716
RX   PubMed=22870217;
RX   PubMed=26351324;
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
RX   PubMed=22870217; DOI=10.1371/journal.pone.0041401;
RA   Saini V., Hose C.D., Monks A., Nagashima K., Han B.-N., Newton D.L.,
RA   Millione A., Shah J., Hollingshead M.G., Hite K.M., Burkett M.W.,
RA   Delosh R.M., Silvers T.E., Scudiero D.A., Shoemaker R.H.;
RT   "Identification of CBX3 and ABCA5 as putative biomarkers for tumor
RT   stem cells in osteosarcoma.";
RL   PLoS ONE 7:E41401-E41401(2012).
//
RX   PubMed=26351324; DOI=10.1158/1535-7163.MCT-15-0074;
RA   Teicher B.A., Polley E.C., Kunkel M., Evans D., Silvers T.E.,
RA   Delosh R.M., Laudeman J., Ogle C., Reinhart R., Selby M., Connelly J.,
RA   Harris E., Monks A., Morris J.;
RT   "Sarcoma cell line screen of oncology drugs and investigational agents
RT   identifies patterns associated with gene and microRNA expression.";
RL   Mol. Cancer Ther. 14:2452-2462(2015).
//